WallStreetZenWallStreetZen

NASDAQ: NEO
Neogenomics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Neogenomics earnings were -$32.3M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest NEO earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$7.5M, down 437.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NEO reported annual earnings of -$108.0M, with 37.2% growth.

NEO earnings history

Current Revenue
$787.8M
Current Earnings
-$32.3M
Current Profit Margin
-4.1%

NEO Return on Equity

Current Company
-4%
Current Industry
548.7%
Current Market
37.4%
NEO's Return on Equity (-4%)... subscribe to Premium to read more.
High Return on Equity Performance

NEO Return on Assets

Current Company
-2.4%
Current Industry
6%
NEO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NEO announces earnings.

NEO Return on Capital Employed

Current Company
-2.61%
Current Industry
10.9%
NEO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NEO vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NEO$39.43M-$32.30MN/A-$0.24
NEOG$112.03M-$56.12MN/A-$0.26
PSNL-$108.90M-$119.33MN/A-$1.17
OPK-$45.33M-$148.06MN/A-$0.19
FRNM-$242.74M-$283.58MN/A-$10.72
View Top Diagnostic & Research Stocks

Neogenomics Earnings Reports & History FAQ

What were Neogenomics's earnings last quarter?

On NEO's earnings call on Oct 28, 2026, Neogenomics (NASDAQ: NEO) reported Q3 2026 earnings per share (EPS) of -$0.06, up 71.43% year over year. Total NEO earnings for the quarter were -$7.55 million. In the same quarter last year, Neogenomics's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Neogenomics stock.

Is Neogenomics profitable or losing money?

As of the last Neogenomics earnings report, Neogenomics is currently losing money. Neogenomics's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$32.30 million, a 71.54% decrease year over year.

What was NEO's earnings growth in the past year?

As of Neogenomics's earnings date in Oct 28, 2026, Neogenomics's earnings has grown year over year. NEO earnings in the past year totalled -$32.30 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.